Faster for Pharma
Sitting Down With... Melissa Hanna-Brown, Analytical Technology & Innovation Lead, Pfizer Global R&D, Sandwich, UK.
What is your current role at Pfizer?
I coordinate Pfizer’s pharmaceutical sciences external collaborations in analytical technology, which means bringing in new technologies that can accelerate the process of making new medicines.
You worked in academia previously…
I had a separation science lectureship in the pharmaceutical department at King’s College, London. I love teaching – seeing the “lights go on.” And I still teach separation science as part of my visiting position at Warwick University. My first role at Pfizer was technology-focused; I worked with the Pfizer Analytical Research Center, collaborating with people like Pat Sandra and Paul Haddad, so my role then was a hybrid between academia and industry. After that, I spent time leading analytical teams and learned more about the business, and now I’ve gone back to the technology side – but with a new understanding of how that technology is applied.
Enjoy our FREE content!
Log in or register to read this article in full and gain access to The Translational Scientist’s entire content archive. It’s FREE and always will be!